Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Delirium | 6 | 2021 | 1061 | 1.60 | Why? |
| Pain Measurement | 3 | 2018 | 533 | 1.12 | Why? |
| Pain Management | 3 | 2018 | 854 | 0.77 | Why? |
| Behavior Observation Techniques | 1 | 2018 | 16 | 0.76 | Why? |
| Emergence Delirium | 1 | 2018 | 15 | 0.74 | Why? |
| Intensive Care Units | 12 | 2021 | 29594 | 0.66 | Why? |
| Cardiac Surgical Procedures | 3 | 2018 | 1931 | 0.63 | Why? |
| Intubation | 1 | 2018 | 437 | 0.62 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.55 | Why? |
| Pneumothorax | 1 | 2021 | 758 | 0.47 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.46 | Why? |
| Poland | 4 | 2018 | 2368 | 0.40 | Why? |
| Critical Care | 5 | 2021 | 14081 | 0.34 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.33 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.28 | Why? |
| Eye Diseases, Hereditary | 1 | 2020 | 17 | 0.22 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.19 | Why? |
| Morphine | 1 | 2018 | 71 | 0.18 | Why? |
| Europe, Eastern | 1 | 2017 | 88 | 0.18 | Why? |
| Acute-Phase Proteins | 1 | 2018 | 177 | 0.17 | Why? |
| Lipocalin-2 | 1 | 2018 | 156 | 0.17 | Why? |
| Analgesics, Non-Narcotic | 1 | 2018 | 164 | 0.17 | Why? |
| Midazolam | 1 | 2017 | 79 | 0.17 | Why? |
| Dexmedetomidine | 1 | 2018 | 130 | 0.16 | Why? |
| Proto-Oncogene Proteins | 1 | 2018 | 340 | 0.16 | Why? |
| Toll-Like Receptor 2 | 1 | 2017 | 198 | 0.15 | Why? |
| Patient Care Bundles | 1 | 2017 | 137 | 0.15 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.15 | Why? |
| Gene Frequency | 1 | 2020 | 1210 | 0.15 | Why? |
| Cannula | 1 | 2021 | 750 | 0.15 | Why? |
| Retinal Diseases | 1 | 2020 | 441 | 0.14 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.13 | Why? |
| Knowledge | 1 | 2017 | 452 | 0.13 | Why? |
| Iron | 1 | 2018 | 619 | 0.12 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.12 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.12 | Why? |
| Coronary Artery Bypass | 1 | 2018 | 629 | 0.12 | Why? |
| Safety | 1 | 2020 | 1583 | 0.12 | Why? |
| Nasal Cavity | 1 | 2017 | 909 | 0.11 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.11 | Why? |
| Language | 1 | 2017 | 655 | 0.11 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.11 | Why? |
| Genotype | 2 | 2020 | 4697 | 0.11 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.10 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.10 | Why? |
| Pain | 1 | 2017 | 1084 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.09 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.08 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.08 | Why? |
| Humans | 18 | 2021 | 930598 | 0.08 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.08 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| Length of Stay | 3 | 2018 | 11042 | 0.08 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.07 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.05 | Why? |
| Aged | 6 | 2020 | 215776 | 0.05 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.05 | Why? |
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2020 | 256 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.04 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.04 | Why? |
| Male | 7 | 2021 | 367725 | 0.04 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.04 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.04 | Why? |
| Early Ambulation | 1 | 2017 | 102 | 0.04 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2017 | 116 | 0.04 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.04 | Why? |
| Vital Capacity | 1 | 2018 | 399 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2018 | 520 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Spirometry | 1 | 2018 | 524 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Animals | 2 | 2020 | 78931 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Respiration | 1 | 2017 | 729 | 0.03 | Why? |
| Female | 5 | 2018 | 380317 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Medicine | 1 | 2017 | 485 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
| Physical Therapy Modalities | 1 | 2018 | 1090 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.02 | Why? |
| Carrier State | 1 | 2017 | 2100 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Family | 1 | 2017 | 2909 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
Kotfis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(78)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_